Latest News about TAK
Recent news which mentions TAK
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
From Benzinga
From Benzinga
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
June 18, 2024
From Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 17, 2024
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
June 17, 2024
From Benzinga
From Benzinga
7 F-Rated Stocks to Avoid at All Costs in June
June 06, 2024
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Why Is AC Immune (ACIU) Stock Up 45% Today?
May 13, 2024
From InvestorPlace
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
May 09, 2024
From Benzinga
Tickers
TAK
From InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
From Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
From InvestorPlace
From Benzinga
Good News For Sleep Disorder Patients - Takeda's Therapy Shows Promise In Mid-Stage Study
February 09, 2024
From Benzinga
Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?
February 01, 2024
From Benzinga
Earnings Scheduled For February 1, 2024
February 01, 2024
From Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
January 23, 2024
From InvestorPlace
Looking Into Takeda Pharmaceutical's Recent Short Interest
January 15, 2024
Tickers
TAK
From Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
December 29, 2023
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
December 25, 2023
Tickers
TAK
From Benzinga
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
December 07, 2023
Tickers
TAK
From Benzinga
Peering Into Takeda Pharmaceutical's Recent Short Interest
November 21, 2023
Tickers
TAK
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.